MedTrace Logo

The Role of Genetic Factors in the Development of Epilepsy in the Kazakh Population

NCT05088499 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2023-03-14

No results posted yet for this study

Summary

This is a GWAS study that aims to identify possible candidate genes associate to epilepsy by exploring single nucleotide polymorphism (SNP) in a group of epilepsy, in the Kazakh population. The investigators hypothesize that the careful phenotyping of the subject sand matching with increase the power to find SNP significantly associate with epilepsy

Conditions

Interventions

GENETIC

DNA analysis

GWAS

Sponsors & Collaborators

  • Asfendiyarov Kazakh National Medical University

    lead OTHER

Principal Investigators

  • Altynshash Jaxybayeva · Astana Medical University, Nur-Sultan, Kazakhstan

Eligibility

Min Age
0 Years
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-01-20
Completion
2023-01-20

Countries

  • Kazakhstan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05088499 on ClinicalTrials.gov